Inscription Capital, LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 87 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
Inscription Capital, LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,440
-25.5%
12,0000.0%0.01%
-22.2%
Q2 2023$30,120
+43.4%
12,0000.0%0.01%
+50.0%
Q1 2023$21,000
-70.9%
12,000
-29.4%
0.01%
-76.0%
Q4 2022$72,250
+261.2%
17,0000.0%0.02%
+316.7%
Q3 2022$20,000
+17.6%
17,0000.0%0.01%
+100.0%
Q2 2022$17,000
-59.5%
17,0000.0%0.00%
-75.0%
Q1 2022$42,000
-8.7%
17,0000.0%0.01%
-7.7%
Q4 2021$46,000
-45.9%
17,0000.0%0.01%
-51.9%
Q3 2021$85,000
-15.0%
17,0000.0%0.03%
-20.6%
Q1 2021$100,000
+25.0%
17,0000.0%0.03%
+9.7%
Q4 2020$80,000
+37.9%
17,0000.0%0.03%
+19.2%
Q3 2020$58,00017,0000.03%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders